It is hypothesized that BG mitigates neuroinflammation by modulating the PI3K-Akt, MAPK, and other inflammatory pathways via rare saponins, such as ginsenoside F1, thereby contributing to the treatment of depression. The gene discussed is PIK3CA; the disease is depressive symptom measurement.